Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sound Waves Diagnose Blood-Related Diseases

By LabMedica International staff writers
Posted on 16 Jul 2013
A method has been developed that can rapidly quantify variations in the morphology of single red blood cells (RBCs) using light and sound. More...


When irradiated with a laser pulse, an RBC absorbs the optical energy and emits an ultrasonic pressure wave called a photoacoustic wave, which contains distinctive features that can be used to identify the erythrocyte’s size.

Biophysicists at Ryerson University (Toronto, ON, Canada) used a special photoacoustic microscope that detects sound. They were able to differentiate healthy red blood cells from irregularly shaped red blood cells with high confidence, using a very small sample size. Because each measurement takes only fractions of a second, the method could eventually be incorporated into an automated device for rapid characterization of red blood cells from a single drop of blood obtained in the clinic.

All measurements were completed using a photoacoustic microscope developed by Kibero (Saarbrücken, Germany). This is an Olympus IX81 inverted optical microscope (Tokyo, Japan) fitted with a transducer above the sample stage. Deviations from the regular biconcave shape of a red blood cell are a significant indicator of blood-related diseases, whether they result from genetic abnormalities, from infectious agents, or simply from a chemical imbalance.

As an example, malaria patients' red blood cells are irregularly swollen, while those of patients with sickle cell anemia or drepanocytosis take on a rigid, sickle shape. The scientists used a single wide-bandwidth transducer sensitive to frequencies between 100 MHz and 500 MHz, to differentiate healthy RBCs from irregularly shaped RBCs, such as echinocytes, spherocytes, and swollen RBCs, with high confidence using sample size of just 21 erythrocytes.

The authors concluded that the photoacoustic spectral methods are a first step toward an automated process for the detection of RBC abnormalities via morphological identification with good sensitivity. With some refinement, these methods could eventually be used in a clinical setting to help diagnose RBC pathology using just a single drop of blood. Michael Kolios, PhD, the senior author of the study said, “We plan to make specialized devices that will allow the detection of individual red blood cells and analyze the photoacoustic signals they produce to rapidly diagnose red blood cell pathologies.” The study was published on July 2, 2013, in the Biophysical Journal.

Related Links:

Ryerson University
Kibero
Olympus



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.